Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentrates
I. Schwarzinger(University of Vienna), Klaus Lechner, Ferdinand Haschke, Michael Kundi(Medical University of Vienna), C Korninger(University of Vienna), H. Niessner, Ingrid Pabinger(Medical University of Vienna)
Cited by 78
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496